Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,1350205,elimination half-lives,"The Cmax and AUC0-infinity values for (+)-(S)-ethotoin were significantly greater than those for (-)-(R)-ethotoin (ratio of mean AUC0-infinity values 0.88), but the elimination half-lives of the isomers were virtually identical [12.35 +/- 5.15 h for (-)-(R)-ethotoin; 12.28 +/- 5.34 h for (+)-(S)-ethotoin].",Enantioselective pharmacokinetics of ethotoin in humans following single oral doses of the racemate. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/1350205/),h,12.35,129764,DB00754,Ethotoin
,1350205,elimination half-lives,"The Cmax and AUC0-infinity values for (+)-(S)-ethotoin were significantly greater than those for (-)-(R)-ethotoin (ratio of mean AUC0-infinity values 0.88), but the elimination half-lives of the isomers were virtually identical [12.35 +/- 5.15 h for (-)-(R)-ethotoin; 12.28 +/- 5.34 h for (+)-(S)-ethotoin].",Enantioselective pharmacokinetics of ethotoin in humans following single oral doses of the racemate. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/1350205/),h,12.28,129765,DB00754,Ethotoin
,1350205,half-life,The 5-phenylhydantoin was eliminated with a significantly longer half-life (18.69 +/- 6.11 h) than that of ethotoin.,Enantioselective pharmacokinetics of ethotoin in humans following single oral doses of the racemate. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1350205/),h,18.69,129766,DB00754,Ethotoin
,42344,time to peak concentration (Tmax),"The time to peak concentration (Tmax) for mephenytoin was 1 hour, with a half-life (T 1/2) of 7 hours; the T 1/2 of its metabolite, 5-ethyl-5-phenylhydantion, was 96 hours.",Clinical pharmacology of mephenytoin and ethotoin. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/42344/),h,1,259166,DB00754,Ethotoin
,42344,half-life (T 1/2),"The time to peak concentration (Tmax) for mephenytoin was 1 hour, with a half-life (T 1/2) of 7 hours; the T 1/2 of its metabolite, 5-ethyl-5-phenylhydantion, was 96 hours.",Clinical pharmacology of mephenytoin and ethotoin. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/42344/),h,7,259167,DB00754,Ethotoin
,42344,T 1/2,"The time to peak concentration (Tmax) for mephenytoin was 1 hour, with a half-life (T 1/2) of 7 hours; the T 1/2 of its metabolite, 5-ethyl-5-phenylhydantion, was 96 hours.",Clinical pharmacology of mephenytoin and ethotoin. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/42344/),h,96,259168,DB00754,Ethotoin
,42344,Tmax,"Ethotoin Tmax was 2 hours, with a T 1/2 of 5 hours.",Clinical pharmacology of mephenytoin and ethotoin. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/42344/),h,2,259169,DB00754,Ethotoin
,42344,T 1/2,"Ethotoin Tmax was 2 hours, with a T 1/2 of 5 hours.",Clinical pharmacology of mephenytoin and ethotoin. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/42344/),h,5,259170,DB00754,Ethotoin
